1. V.T. De Vita, in: V.T. De Vita, S. Hellmann, S.A. Rosemberg (Editors), Cancer principles and practice of oncology, Lippincott, Philadelphia, 1989, Ch. 18, p. 376.
2. B.K. Sinha, P.M. Politi, in: H.L. Pinedo, D.L. Longo, B.A. Chebner (Editors), Cancer chemotherapy and biological response modifiers Annual 11, Elsevier, Amsterdam, 1990, p. 45.
3. Clinical Pharmacokinetics of Doxorubicin
4. Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
5. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses